Read More This new drug delivery method could offer long-lasting relief for eye diseases By Safa Jinje|January 31, 2025 Colloidal drug aggregates prolong effect of glaucoma medicine up to seven weeks with a single, non-invasive injection
Read More Research to improve eye disease treatments wins 2023 NSERC Brockhouse Canada Prize By Safa Jinje|November 1, 2023 Professor Frank Gu (ChemE), a member of the winning team, is engineering nanomedicines to delay or prevent irreversible blindness caused by glaucoma
Read More Online simulator could help glaucoma patients and doctors better understand disease progression By Matthew Tierney|September 15, 2023 Professor Willy Wong and grad student Yan Li (both ECE) used a data-driven model that takes into account how the eye functions to simulate the progression of glaucoma